Literature DB >> 12108794

Diabetic ketoacidosis depletes plasma tryptophan.

G F Carl1, William H Hoffman, Paul R Blankenship, Mark S Litaker, Martin G Hoffman, P Alex Mabe.   

Abstract

Diabetic ketoacidosis (DKA) is a severe metabolic disturbance of insulin-dependent diabetes mellitus (IDDM) which has a significant effect on amino acid metabolism. Amino acids serve as precursors for various neurotransmitters which are involved in affective disorders, and patients with IDDM are known to have an increased prevalence of affective disorders. We monitored the plasma concentrations of 23 amino acids in six adolescents prior to treatment of DKA and at 6, 24 and 120 hours after initiation of treatment. The well-known increase in the concentrations of the glucogenic amino acids and the decrease in the branched-chain amino acids were observed in response to treatment of DKA. Low levels of tryptophan were found prior to treatment of DKA. Treatment increased the plasma tryptophan levels, but the mean concentration remained low throughout the sampling period. Only the glutamate-derived amino acids (glutamate, proline and glutamine) from the Krebs cycle pool were significantly affected by treatment. Glutamine declined initially, but recovered as the plasma pH normalized. Our results indicate that DKA causes a depletion of plasma tryptophan. This depletion may predispose some patients with IDDM to have affective disorders secondary to a neurotransmitter imbalance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12108794     DOI: 10.1081/erc-120004541

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  6 in total

Review 1.  Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis.

Authors:  William H Hoffman; John J Shacka; Anuska V Andjelkovic
Journal:  Exp Mol Pathol       Date:  2011-11-06       Impact factor: 3.362

2.  Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Cornelia D Cudrici; Dallas Boodhoo; Alexandru Tatomir; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2019-04-13       Impact factor: 3.362

3.  Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study.

Authors:  Isabella Melena; Federica Piani; Kalie L Tommerdahl; Cameron Severn; Linh T Chung; Alexis MacDonald; Carissa Vinovskis; David Cherney; Laura Pyle; Carlos A Roncal-Jimenez; Miguel A Lanaspa; Arleta Rewers; Daniël H van Raalte; Gabriel Cara-Fuentes; Chirag R Parikh; Robert G Nelson; Meda E Pavkov; Kristen J Nadeau; Richard J Johnson; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2022-04-28       Impact factor: 3.219

4.  Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis.

Authors:  Farook Jahoor; Jean W Hsu; Paras B Mehta; Kelly R Keene; Ruchi Gaba; Surya Narayan Mulukutla; Eunice Caducoy; W Frank Peacock; Sanjeet G Patel; Rasmus Bennet; Ake Lernmark; Ashok Balasubramanyam
Journal:  Diabetes       Date:  2021-05-21       Impact factor: 9.337

5.  Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.

Authors:  William H Hoffman; Stephen A Whelan; Norman Lee
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

6.  Effects of Diabetic Ketoacidosis on Visual and Verbal Neurocognitive Function in Young Patients Presenting with New-Onset Type 1 Diabetes.

Authors:  Ashley B Jessup; Mary Beth Grimley; Echo Meyer; Gregory P Passmore; Ayşenil Belger; William H Hoffman; Ali S Çalıkoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.